stockportfolio.pro
Covista Inc. (CVSA)
Consumer Defensive · Education & Training Services · NYSE
Covista Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.21B | $960.28M | $1.01B | $866.43M | $899.25M | $1.39B | $1.45B | $1.58B | $1.79B |
| Gross profit | $511.13M | $569.66M | $498.72M | $542.06M | $409.26M | $441.34M | $727.35M | $802.34M | $886.10M | $1.02B |
| Net income | $-3.17M | $122.28M | $33.77M | $95.17M | $-85.33M | $70.03M | $317.70M | $93.36M | $136.78M | $237.06M |
| Net margin | -0.3% | 10.1% | 3.5% | 9.4% | -9.8% | 7.8% | 22.9% | 6.4% | 8.6% | 13.3% |
Source: Covista Inc. SEC filings (10-K). 17 years of history available in the interactive view.
What growth is priced into CVSA stock?
At today's market cap of $4.40B, Covista Inc. is priced for free-cash-flow growth of about 4.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $287.57M from the FY ending 2025-06-30). For comparison, free cash flow actually grew 33.4%/yr over the last five fiscal years and revenue 15.6%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 17 years of Covista Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CVSA in your portfolio →
Covista Inc. financial history by metric
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Covista Inc. — frequently asked questions
What is Covista Inc.'s revenue?
Covista Inc. (CVSA) reported revenue of $1.79B for fiscal year 2025, up 12.9% from the prior year, according to its SEC filings.
Is Covista Inc. profitable?
Yes. CVSA earned net income of $237.06M in fiscal 2025, a net margin of 13.3%.
What is CVSA's P/E ratio?
Covista Inc. trades at a price-to-earnings ratio of about 18.8 based on the latest data in our nightly-refreshed cache.
How fast is Covista Inc. growing?
CVSA's revenue grew at roughly 15.6% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Covista Inc. have?
As of fiscal year 2025, CVSA carried roughly $552.67M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Covista Inc.'s gross margin?
CVSA's gross margin was 56.9% in fiscal 2025 — gross profit of $1.02B on revenue of $1.79B.
What is Covista Inc.'s market cap?
Covista Inc. (CVSA) has a market capitalization of about $4.40B, based on the latest data in our nightly-refreshed cache.
When does Covista Inc.'s fiscal year end?
CVSA's fiscal year ends in June. Its most recent annual filing covers the fiscal year ending 2025-06-30.
What growth is priced into CVSA stock?
At today's market cap of $4.40B, Covista Inc. is priced for free-cash-flow growth of about 4.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $287.57M from the FY ending 2025-06-30). For comparison, free cash flow actually grew 33.4%/yr over the last five fiscal years and revenue 15.6%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Covista Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.